07.01.2019 • News

Sylvie Lemoine Joins CEFIC as Executive Director Product Stewardship

Sylvie Lemoine Joins CEFIC as Executive Director Product Stewardship (c) ECHA
Sylvie Lemoine Joins CEFIC as Executive Director Product Stewardship (c) ECHA

The European Chemical Industry Council (CEFIC) has appointed Sylvie Lemoine, senior manager Government Affairs at Dow, as its executive director Product Stewardship effective immediately. She succeeds Peter Smith, who has retired from the organization.

In her new role, Lemoine will be responsible for the key chemical legislation topics, including the implementation of REACh, an EU framework for endocrine disruptors, and the interface between chemicals, products and waste.

Marco Mensink, CEFIC’s director general, said: “Sylvie brings a unique skill set to the Product Stewardship team. The combination of her advocacy experience in Brussels with an in-depth technical knowledge of the EU chemicals legislation makes her a perfect fit for this role. I would like to thank outgoing executive director Peter Smith for his contribution to the Product Stewardship team over the past seven years.”

Lemoine has more than 10 years of experience in EU government affairs. Prior to joining Dow Corning in 2016, she was director for Technical and Regulatory Affairs at the International Association for Soaps, Detergents and Maintenance Products (AISE). She holds a PhD in organic chemistry from the Louis Pasteur University in Strasbourg, France and started her career at ExxonMobil Chemical.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.